此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

剖腹产术后疼痛管理

2026年11月3日 更新者:Chi-Hsu Wang、Mackay Memorial Hospital

剖腹产术后疼痛管理:一项前瞻性、观察性队列研究

Caesarean section is one of the most frequent surgeries causing severe postoperative pain. Poor management of acute pain can contribute to postoperative complications, late recovery and the development of chronic pain. Moreover, it had been demonstrated that the intensity of postpartum pain is associated with depression. It is imperative to find out appropriate methods of postpartum pain alleviation. Currently, a lot of analgesic drugs and methods have been developed and used in clinical practice, such as patient-controlled analgesia, extended-release analgesics and multimodal analgesia. This prospective cohort study is aimed to investigate the outcome of each postoperative analgesic method used in caesarean section.

研究概览

详细说明

This is a prospective, observational, cohort study. Patients undergoing elective caesarean section will be invited to the study. The written informed consent will be obtained prior to participation. After getting the written informed consent, data will be collected from medical records, questionnaires, patient diaries, visit records and telephone visit records. Through telephone visits, postpartum depression scale and postpartum chronic pain will be evaluated six weeks and three months after delivery. Demographic data, consumption of analgesics, analgesic methods, intensity of postoperative pain, complications, recovery time, score of depression scale will all be summarized. Numerical variables will be present with mean and standard deviation and categorical variables will be present with number and percentage.

研究类型

观察性的

注册 (实际的)

74

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • New Taipei City、台湾、251
        • MacKay Memorial Hospital Tamsui Branch
      • Taipei、台湾、104
        • MacKay Memorial Hospital

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

20年 至 40年 (成人)

接受健康志愿者

不

有资格学习的性别

女性

取样方法

非概率样本

研究人群

Pregnant woman scheduled to have caesarean section within 30 days.

描述

Inclusion Criteria:

  1. Aged 20 to 40.
  2. Planing to undergo caesarean section with spinal anesthesia.
  3. Scheduled to undergo cesarean section between 37 and 40 weeks of gestation.
  4. American Society of Anesthesiology Physical Class 1-2.
  5. Planing to alleviate postoperative pain with intravenous patient-controlled analgesia or administration of NALDEBAIN.

Exclusion Criteria:

  1. Not willing to provide informed consent.
  2. Unable to receive opioids or NSAIDs due to contraindication.
  3. Long-term use of opioids or drug abuse.
  4. Suffering from chronic pain disease.
  5. Having medical history of mental illnesses.
  6. Diagnosed with Pre-eclampsia or eclampsia.
  7. Diagnosed with gestational diabetes.
  8. Unsuitable for participation judged by investigator.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 观测模型:COHORT
  • 时间观点:PROSPECTIVE

队列和干预

团体/队列
干预/治疗
IV-PCA + NALDEBAIN group

Patients treated with the combination of IV-PCA and intramuscular injection of dinalbuphine sebacate will be allocated to IV-PCA + NALDEBAIN group.

At the two trial sites, IV-PCA is commonly used with morphine. The device is installed after delivery and removed within 3 days.

其他名称:
  • IV-主成分分析

Dinalbuphine sebacate is a prodrug of nalbuphine. With oil-based formulation, the active ingredient releases slowly and the effect lasts longer than nalbuphine. After delivery, a single 150 mg dose of dinalbuphine sebacate is administered intramuscularly.

其他名称:
  • 纳德班
IV-PCA group

Patients receiving intravenous patient-controlled analgesia (IV-PCA) will be allocated to IV-PCA group.

At the two trial sites, IV-PCA is commonly used with morphine. The device is installed after delivery and removed within 3 days.

其他名称:
  • IV-主成分分析

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Postpartum pain intensity
大体时间:Within 5 days after delivery

Pain intensity is assessed by numerical rating scale (NRS) at least twice daily during hospital stay after delivery. NRS is a 11-point scale which labeled from zero (no pain) to ten (worst pain). The area under the curve of NRS are calculated.

Within 5 days after delivery

次要结果测量

结果测量
措施说明
大体时间
Consumption of analgesics
大体时间:Within 5 days after delivery

The mean total consumption of analgesics during the hospital stay after delivery.

Within 5 days after delivery
Incidence of complications
大体时间:Up to 5 days after delivery

the incidence of postoperative complication occurring during hospital stay after delivery, especially the ones related to analgesics.

Up to 5 days after delivery
Ambulation
大体时间:Up to 5 days after delivery

The mean length of time between delivery and the first ambulation.

Up to 5 days after delivery
Breastfeeding
大体时间:Up to 5 days after delivery

The percentage of participants able to breastfeed during hospital stay and the mean length of time between delivery and the first breastfeeding.

Up to 5 days after delivery
Gastrointestinal function recovery
大体时间:Up to 5 days after delivery

The mean length of time between delivery and first soft diet.

Up to 5 days after delivery
Postnatal Depression assessment
大体时间:At baseline, 6 weeks and 3 months after delivery

Edinburgh Postnatal Depression questionnaire is used to assess patients' postpartum depression. Participants are asked to fill in the questionnaire at baseline (within 30 days prior to delivery), 6 weeks and 3 months after delivery.

At baseline, 6 weeks and 3 months after delivery
Satisfaction assessed by a four-point scale
大体时间:6 weeks after delivery

Participants are asked to assess the satisfaction toward rate of recovery progress and pain management through 6 questions six weeks after delivery. Each question contain 4 choices: very satisfied, satisfied, dissatisfied and very dissatisfied.

6 weeks after delivery
Chronic pain intensity
大体时间:6 weeks and 3 months after delivery

Chronic pain intensity is assessed by NRS 6 weeks and 3 months after delivery. NRS is a 11-point scale which labeled from zero (no pain) to ten (worst pain).

6 weeks and 3 months after delivery

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Chi-Hsu Wang, M.D.、MacKay Memorial Hospital Tamsui Branch

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2022年2月23日

初级完成 (实际的)

2026年4月30日

研究完成 (实际的)

2026年8月31日

研究注册日期

首次提交

2021年8月3日

首先提交符合 QC 标准的

2021年8月12日

首次发布 (实际的)

2021年8月18日

研究记录更新

最后更新发布 (实际的)

2026年11月6日

上次提交的符合 QC 标准的更新

2026年11月3日

最后验证

2026年11月1日

更多信息

与本研究相关的术语

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅